Middle East Pharmaceutical Industries Company (TADAWUL:4016)

TADAWUL:4016 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,632	2,436	-	-	-	-
Enterprise Value	2,675	2,496	-	-	-	-
Last Close Price	131.60	121.80	-	-	-	-
PE Ratio	42.32	30.51	-	-	-	-
Forward PE	26.86	24.86	-	-	-	-
PS Ratio	8.58	6.18	-	-	-	-
PB Ratio	15.26	6.62	-	-	-	-
P/TBV Ratio	7.67	7.67	-	-	-	-
P/FCF Ratio	109.09	100.97	-	-	-	-
P/OCF Ratio	69.02	69.02	-	-	-	-
EV/Sales Ratio	6.79	6.33	-	-	-	-
EV/EBITDA Ratio	25.03	23.35	-	-	-	-
EV/EBIT Ratio	29.38	27.42	-	-	-	-
EV/FCF Ratio	110.87	103.45	-	-	-	-
Debt / Equity Ratio	0.18	0.18	0.20	0.30	0.33	0.25
Debt / EBITDA Ratio	0.61	0.61	0.70	1.11	1.05	0.72
Debt / FCF Ratio	2.71	2.71	0.83	1.44	3.44	5.49
Asset Turnover	0.81	0.81	0.76	0.70	0.73	-
Inventory Turnover	1.67	1.67	1.40	1.37	1.45	-
Quick Ratio	1.79	1.79	1.53	1.36	1.59	1.52
Current Ratio	2.65	2.65	2.45	2.22	2.30	2.66
Return on Equity (ROE)	23.67%	23.67%	22.44%	21.72%	25.52%	-
Return on Assets (ROA)	11.71%	11.71%	10.92%	10.10%	12.09%	-
Return on Capital (ROIC)	14.23%	14.23%	13.25%	12.06%	14.23%	-
Return on Capital Employed (ROCE)	23.20%	23.20%	23.40%	22.30%	25.40%	28.20%
Earnings Yield	3.03%	3.28%	-	-	-	-
FCF Yield	0.92%	0.99%	-	-	-	-
Payout Ratio	18.79%	18.79%	54.69%	61.14%	56.12%	49.80%
Buyback Yield / Dilution	-28.32%	-28.37%	-	-	-	-

Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.